Article Text
Statistics from Altmetric.com
Community emergency medicine (CEM) is a model of pre-hospital care that delivers emergency department care to patients irrespective of their clinical environment.1 2 It is the clinical or situational complexity of the patient, rather than the acuity of illness, that best defines the cohort patients targeted by CEM.
London’s physician response unit (PRU), established in 2001, has continually evolved its scope of practice. During the COVID-19 pandemic, the PRU rapidly developed novel care pathways that targeted patient cohorts felt to be at increased risk from traditional hospital systems.3 As part of this work, the ‘Acute Oncology/CEM partnership’ standard operating procedure (SOP) was developed as a collaboration between the Barts Health Acute Oncology Service (AOS) and the PRU.3 Non-admitted patients known to the AOS are offered 24-hour telephone access to a dedicated nurse-led ‘Chemotherapy Hotline’ (CHL). Patients accessing the CHL are triaged using the UKONS triage tool. The acute oncology/CEM partnership SOP stipulates that only patients who would otherwise attend ED should be referred. Pending availably from other emergency calls, the PRU will see all referred patients. PRU patients are seen by an emergency medicine consultant or registrar working alongside an …
Footnotes
Handling editor Mary Dawood
Contributors JS and NM contributed equally to study design, methodology, data collection, analysis and manuscript drafting.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Provenance and peer review Not commissioned; externally peer reviewed.
Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.